Most patients continue treatment long-term for sustained weight loss
Research-grade peptides are available from Canadian suppliers that provide third-party testing certificates, proper storage, and shipping from within Canada
I think it sends a really terrible message to the public, which just kind of reinstates the stigma around obesity, saying that this is not a disease, this is a choice, she said
Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial
Efficacy and safety of dulaglutide 3.0 mg and 4.5 mg versus dulaglutide 1.5 mg in metformintreated patients with type 2 diabetes in a randomized controlled trial (AWARD11)
If you developed gastroparesis in 2024 but did not learn until 2025 that it could be connected to your GLP-1 medication, the discovery rule may extend your filing deadline